400 related articles for article (PubMed ID: 19660663)
1. The placebo response: neurobiological and clinical issues of neurological relevance.
Pollo A; Benedetti F
Prog Brain Res; 2009; 175():283-94. PubMed ID: 19660663
[TBL] [Abstract][Full Text] [Related]
2. Placebo response: relevance to the rheumatic diseases.
Pollo A; Benedetti F
Rheum Dis Clin North Am; 2008 May; 34(2):331-49. PubMed ID: 18638680
[TBL] [Abstract][Full Text] [Related]
3. Placebo analgesia.
Benedetti F
Neurol Sci; 2006 May; 27 Suppl 2():S100-2. PubMed ID: 16688609
[TBL] [Abstract][Full Text] [Related]
4. [Placebo, placebo effect and clinical trials].
de la Fuente-Fernández R
Neurologia; 2007 Mar; 22(2):69-71. PubMed ID: 17323230
[TBL] [Abstract][Full Text] [Related]
5. Expectations and associations that heal: Immunomodulatory placebo effects and its neurobiology.
Pacheco-López G; Engler H; Niemi MB; Schedlowski M
Brain Behav Immun; 2006 Sep; 20(5):430-46. PubMed ID: 16887325
[TBL] [Abstract][Full Text] [Related]
6. Imaging the placebo response: a neurofunctional review.
Faria V; Fredrikson M; Furmark T
Eur Neuropsychopharmacol; 2008 Jul; 18(7):473-85. PubMed ID: 18495442
[TBL] [Abstract][Full Text] [Related]
7. Would the elderly be better off if they were given more placebos?
Cherniack EP
Geriatr Gerontol Int; 2010 Apr; 10(2):131-7. PubMed ID: 20100289
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of the placebo effect and of conditioning.
Haour F
Neuroimmunomodulation; 2005; 12(4):195-200. PubMed ID: 15990450
[TBL] [Abstract][Full Text] [Related]
9. Brain mechanisms underlying the placebo effect in neurological disorders.
Cavanna AE; Strigaro G; Monaco F
Funct Neurol; 2007; 22(2):89-94. PubMed ID: 17637211
[TBL] [Abstract][Full Text] [Related]
10. Categories of placebo response in the absence of site-specific expectation of analgesia.
Watson A; El-Deredy W; Bentley DE; Vogt BA; Jones AK
Pain; 2006 Dec; 126(1-3):115-22. PubMed ID: 16890357
[TBL] [Abstract][Full Text] [Related]
11. [Placebo effect and pain: brain bases].
Ramos JM
Neurologia; 2007 Mar; 22(2):99-105. PubMed ID: 17323235
[TBL] [Abstract][Full Text] [Related]
12. Placebo mechanisms and reward circuitry: clues from Parkinson's disease.
de la Fuente-Fernández R; Schulzer M; Stoessl AJ
Biol Psychiatry; 2004 Jul; 56(2):67-71. PubMed ID: 15231437
[TBL] [Abstract][Full Text] [Related]
13. Placebo theory and its implications for research and clinical practice: a review of the recent literature.
Koshi EB; Short CA
Pain Pract; 2007 Mar; 7(1):4-20. PubMed ID: 17305673
[TBL] [Abstract][Full Text] [Related]
14. Trial methodology and patient characteristics did not influence the size of placebo effects on pain.
Kamper SJ; Machado LA; Herbert RD; Maher CG; McAuley JH
J Clin Epidemiol; 2008 Mar; 61(3):256-60. PubMed ID: 18226748
[TBL] [Abstract][Full Text] [Related]
15. Who controls the placebo? Introducing a Placebo Quality Checklist for pharmacological trials.
Brinkhaus B; Pach D; Lüdtke R; Willich SN
Contemp Clin Trials; 2008 Mar; 29(2):149-56. PubMed ID: 17669693
[TBL] [Abstract][Full Text] [Related]
16. How placebos change the patient's brain.
Benedetti F; Carlino E; Pollo A
Neuropsychopharmacology; 2011 Jan; 36(1):339-54. PubMed ID: 20592717
[TBL] [Abstract][Full Text] [Related]
17. The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies.
Diederich NJ; Goetz CG
Neurology; 2008 Aug; 71(9):677-84. PubMed ID: 18725593
[TBL] [Abstract][Full Text] [Related]
18. Placebo and nocebo in interventional pain management: a friend or a foe--or simply foes?
Manchikanti L; Giordano J; Fellows B; Hirsch JA
Pain Physician; 2011; 14(2):E157-75. PubMed ID: 21412379
[TBL] [Abstract][Full Text] [Related]
19. Pain and the placebo: what we have learned.
Hoffman GA; Harrington A; Fields HL
Perspect Biol Med; 2005; 48(2):248-65. PubMed ID: 15834197
[TBL] [Abstract][Full Text] [Related]
20. Great expectations: the placebo effect in Parkinson's disease.
Lidstone SC
Handb Exp Pharmacol; 2014; 225():139-47. PubMed ID: 25304530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]